GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 20751 - 20800 of 39437 in total
PDB ID UniProt ID Title ▲ Descriptor
6X9V 6X9V HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain
6X9U Q2N0S6 HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain
6X9U 6X9U HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain
6MAR Q2N0S6 HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody Fab PGT151 Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151, Light chain, Envelope glycoprotein gp160
6MAR Q2N0S7 HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody Fab PGT151 Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151, Light chain, Envelope glycoprotein gp160
6MAR 6MAR HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody Fab PGT151 Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151, Light chain, Envelope glycoprotein gp160
1GC1 P01730 HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
1GC1 P04578 HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
1GC1 1GC1 HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
1G9M P01730 HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1G9M P04578 HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1G9M 1G9M HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1RZJ P01730 HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1RZJ P04578 HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1RZJ 1RZJ HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3VQA Q72498 HIV-1 IN core domain in complex with 1-benzothiophen-6-amine 1,1-dioxide
3VQ7 Q72498 HIV-1 IN core domain in complex with 4-(1H-pyrrol-1-yl)aniline
2BGN P27487 HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26)
2BGN P56658 HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26)
2BGN 2BGN HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26)
2BGN P56658 HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26)
2BGN 2BGN HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26)
2BGN P12506 HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26)
1G9N P01730 HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1G9N P35961 HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1G9N 1G9N HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1RZK P01730 HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1RZK 1RZK HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
6UDJ S6B2B6 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ 6UDJ HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ S6B2B6 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ 6UDJ HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ Q8N355 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ Q8N355 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ Q2N0S6 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ Q6PIL8 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ Q6PIL8 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDK S6B2B6 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK 6UDK HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK S6B2B6 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK 6UDK HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK Q8N355 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK Q8N355 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK S6C4S0 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK S6C4S0 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK Q6PJF2 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK Q6PJF2 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
2NY1 Q993A8 HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b
2NY1 P01730 HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b
2NY1 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024